Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AdaptHealth (AHCO) Shares Outstanding (Diluted Average) (2020 - 2026)

AdaptHealth has reported Shares Outstanding (Diluted Average) over the past 6 years, most recently at $135.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) changed 0.28% year-over-year to $135.1 million; the TTM value through Dec 2025 reached $135.1 million, changed 0.28%, while the annual FY2025 figure was $135.1 million, 0.28% changed from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $135.1 million at AdaptHealth, down from $137.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $139.0 million in Q4 2022 and troughed at $132.9 million in Q1 2024.
  • A 5-year average of $135.9 million and a median of $136.0 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 153.46% in 2021 and later dropped 3.29% in 2023.
  • Year by year, Shares Outstanding (Diluted Average) stood at $133.0 million in 2021, then rose by 4.48% to $139.0 million in 2022, then fell by 3.29% to $134.4 million in 2023, then rose by 0.83% to $135.5 million in 2024, then decreased by 0.28% to $135.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for AHCO at $135.1 million in Q4 2025, $137.1 million in Q3 2025, and $137.1 million in Q2 2025.